ARTICLE | Clinical News
Bifunctional haptenization and dyed microparticles regulatory update
June 12, 2000 7:00 AM UTC
Xtrana received U.S. Patent No. 5,989,813 covering the visual or fluorescent detection of amplified target nucleic acid sequences using haptenized oligonucleotides. Xtrana is merging with Biopool Int...